Boehringer doubles down on T-cell based discovery partnership with 3T
05 Jan 2024 //
PR NEWSWIRE
Boehringer Ingelheim and 3T Biosciences enter into a second partnership
04 Jan 2024 //
PR NEWSWIRE
3T Biosciences Expands Leadership Team With Bryan Irving as CSO
25 Oct 2023 //
PR NEWSWIRE